Literature DB >> 21948176

Essential roles for Pot1b in HSC self-renewal and survival.

Yang Wang1, Mei-Feng Shen, Sandy Chang.   

Abstract

Maintenance of mammalian telomeres requires both the enzyme telomerase and shelterin, which protect telomeres from inappropriately activating DNA damage response checkpoints. Dyskeratosis congenita is an inherited BM failure syndrome disorder because of defects in telomere maintenance. We have previously shown that deletion of the shelterin component Pot1b in the setting of telomerase haploinsufficiency results in rapid telomere shortening and fatal BM failure in mice, eliciting phenotypes that strongly resemble human syskeratosis congenita. However, it was unclear why BM failure occurred in the setting of Pot1b deletion. In this study, we show that Pot1b plays an essential role in HSC survival. Deletion of Pot1b results in increased apoptosis, leading to severe depletion of the HSC reserve. BM from Pot1b(Δ/Δ) mice cannot compete with BM from wild-type mice to provide multilineage reconstitution, indicating that there is an intrinsic requirement for Pot1b the maintenance of HSC function in vivo. Elimination of the p53-dependent apoptotic function increased HSC survival and significantly extended the lifespan of Pot1b-null mice deficient in telomerase function. Our results document for the first time the essential role of a component of the shelterin complex in the maintenance of HSC and progenitor cell survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21948176      PMCID: PMC3234665          DOI: 10.1182/blood-2011-06-361527

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

Review 1.  Telomere dysfunction and tumour suppression: the senescence connection.

Authors:  Yibin Deng; Suzanne S Chan; Sandy Chang
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716

Review 2.  Telomere maintenance and human bone marrow failure.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

3.  Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome.

Authors:  Anna Marrone; Amanda Walne; Hannah Tamary; Yuka Masunari; Michael Kirwan; Richard Beswick; Tom Vulliamy; Inderjeet Dokal
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

4.  Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita.

Authors:  Hua He; Yang Wang; Xiaolan Guo; Sonal Ramchandani; Jin Ma; Mei-Feng Shen; Dennis A Garcia; Yibin Deng; Asha S Multani; Mingjian James You; Sandy Chang
Journal:  Mol Cell Biol       Date:  2008-10-20       Impact factor: 4.272

5.  Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice.

Authors:  Geng Liu; John M Parant; Gene Lang; Patty Chau; Arturo Chavez-Reyes; Adel K El-Naggar; Asha Multani; Sandy Chang; Guillermina Lozano
Journal:  Nat Genet       Date:  2003-12-21       Impact factor: 38.330

6.  Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1.

Authors:  Eros Lazzerini Denchi; Titia de Lange
Journal:  Nature       Date:  2007-08-08       Impact factor: 49.962

7.  Engineered telomere degradation models dyskeratosis congenita.

Authors:  Dirk Hockemeyer; Wilhelm Palm; Richard C Wang; Suzana S Couto; Titia de Lange
Journal:  Genes Dev       Date:  2008-06-11       Impact factor: 11.361

8.  TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita.

Authors:  Sharon A Savage; Neelam Giri; Gabriela M Baerlocher; Nick Orr; Peter M Lansdorp; Blanche P Alter
Journal:  Am J Hum Genet       Date:  2008-01-31       Impact factor: 11.025

9.  Functional dissection of human and mouse POT1 proteins.

Authors:  Wilhelm Palm; Dirk Hockemeyer; Tatsuya Kibe; Titia de Lange
Journal:  Mol Cell Biol       Date:  2008-10-27       Impact factor: 5.069

10.  TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.

Authors:  Amanda J Walne; Tom Vulliamy; Richard Beswick; Michael Kirwan; Inderjeet Dokal
Journal:  Blood       Date:  2008-07-30       Impact factor: 22.113

View more
  16 in total

1.  CTC1 deletion results in defective telomere replication, leading to catastrophic telomere loss and stem cell exhaustion.

Authors:  Peili Gu; Jin-Na Min; Yang Wang; Chenhui Huang; Tao Peng; Weihang Chai; Sandy Chang
Journal:  EMBO J       Date:  2012-04-24       Impact factor: 11.598

2.  Synergistic tumor suppression by combined inhibition of telomerase and CDKN1A.

Authors:  Romi Gupta; Yuying Dong; Peter D Solomon; Hiromi I Wettersten; Christopher J Cheng; Jin-Na Min; Jeremy Henson; Shaillay Kumar Dogra; Sung H Hwang; Bruce D Hammock; Lihua J Zhu; Roger R Reddel; W Mark Saltzman; Robert H Weiss; Sandy Chang; Michael R Green; Narendra Wajapeyee
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

3.  Critical role of the POT1 OB domain in maintaining genomic stability.

Authors:  T K Pandita
Journal:  Oncogene       Date:  2016-11-21       Impact factor: 9.867

4.  p16(INK4a) protects against dysfunctional telomere-induced ATR-dependent DNA damage responses.

Authors:  Yang Wang; Norman Sharpless; Sandy Chang
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

Review 5.  The shelterin complex and hematopoiesis.

Authors:  Morgan Jones; Kamlesh Bisht; Sharon A Savage; Jayakrishnan Nandakumar; Catherine E Keegan; Ivan Maillard
Journal:  J Clin Invest       Date:  2016-05-02       Impact factor: 14.808

6.  BRPF1 is essential for development of fetal hematopoietic stem cells.

Authors:  Linya You; Lin Li; Jinfeng Zou; Kezhi Yan; Jad Belle; Anastasia Nijnik; Edwin Wang; Xiang-Jiao Yang
Journal:  J Clin Invest       Date:  2016-08-08       Impact factor: 14.808

7.  Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of dyskeratosis congenita.

Authors:  Fabian Beier; Miguel Foronda; Paula Martinez; Maria A Blasco
Journal:  Blood       Date:  2012-08-29       Impact factor: 22.113

8.  Hematopoietic stem cells are acutely sensitive to Acd shelterin gene inactivation.

Authors:  Morgan Jones; Gail Osawa; Joshua A Regal; Daniel N Weinberg; James Taggart; Hande Kocak; Ann Friedman; David O Ferguson; Catherine E Keegan; Ivan Maillard
Journal:  J Clin Invest       Date:  2013-12-09       Impact factor: 19.456

Review 9.  The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation.

Authors:  Limengmeng Wang; Haowen Xiao; Xing Zhang; Chong Wang; He Huang
Journal:  J Hematol Oncol       Date:  2014-08-20       Impact factor: 17.388

Review 10.  The role of telomere binding molecules for normal and abnormal hematopoiesis.

Authors:  Kentaro Hosokawa; Fumio Arai
Journal:  Int J Hematol       Date:  2018-03-17       Impact factor: 2.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.